GlassScriptPhysician profile
Ken C Chiu
NPI 1639126691
$1,717.76
in general payments reported to CMS, 2019-2025
15 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2021: $22.59 · 2022: $28.63 · 2023: $343 · 2024: $610 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152 · Education: $23.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.93 |
| Education | $23.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $495.79 | 2019-2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $386.61 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $301.76 | 2019-2024 | Mounjaro |
| Corcept Therapeutics | $142.92 | 2019-2023 | Korlym |
| Janssen Scientific Affairs, LLC | $122.57 | 2019 | |
| Amgen INC. | $95.88 | 2019-2025 | Tepezza |
| Nestle Healthcare Nutrition INC. | $28.63 | 2022 | |
| Senseonics, Incorporated | $28.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.59 | 2019 | |
| Dexcom, INC. | $22.59 | 2021 | |
| Medtronic, INC. | $22.07 | 2025 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $18.10 | 2025 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $16.18 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.07 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.